High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
about
Leucoreduction of blood components: an effective way to increase blood safety?Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?Human Cytomegalovirus (HCMV) - Revised.One size will never fit all: the future of research in pediatric transfusion medicine.Alternative blood products and clinical needs in transfusion medicineImpact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011.Systematic Evaluation of Different Nucleic Acid Amplification Assays for Cytomegalovirus Detection: Feasibility of Blood Donor Screening.A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.Transfusion support issues in hematopoietic stem cell transplantation.Neopterin in Diagnosis and Monitoring of Infectious Diseases.Transfusion-transmitted CMV infection - current knowledge and future perspectives.Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy.Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.Cytomegalovirus transmission in pediatric renal transplant recipients during the window period.The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting.Comparison of the two fully automated anti-HCMV IgG assays: Abbott Architect CMV IgG assay and Biotest anti-HCMV recombinant IgG ELISA.The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
P2860
Q26771857-3B90241D-FD1C-4C58-B27E-0D6BFD229685Q27005922-90A7704A-1DCF-4170-B138-4D48FFC3F39BQ34625453-0191B687-1D68-4B1A-8724-7AE73DF78DEDQ35535157-328D3B78-8E35-4758-A390-27D463F56561Q35915095-6FD4931A-C3A1-46F6-8321-5750997C7F9CQ36013369-B2582B03-7B70-4DF4-8FCD-4A1136323B40Q36066896-D4DA68B6-C016-44D7-B0C3-45BBB6B00DC6Q38052141-ADD43A33-7405-418C-A882-CEB500ED0377Q38287605-E0BD3D5D-D84B-4C60-90F9-6A3988EBE655Q38575775-C042CF36-3415-4E2D-A041-EC807417B8C0Q38667640-636E4659-0618-4B64-B8A0-ED68BC2225DFQ39849819-4C07E3DE-6B90-4C14-9E82-A7F2EF9493DBQ40218152-29FFB670-CE14-4366-B12F-B1519658A3CEQ40243669-9A59EEC2-4669-43FE-9A3A-30EFE7001C2CQ40261427-D5519503-4C95-4090-ABDF-8169DC81B0C8Q40862316-2949FAD6-2F07-43C7-B352-9D18D92F515DQ41100504-EB218F0F-899D-49A0-9694-517BEAE2764FQ41640997-6D5E694C-4A81-43FF-99E2-49462E55A4AEQ42275032-E1466E04-D1DE-4692-8A0C-A246DB6A7913Q43215972-C719C95D-7002-49B0-A215-A400AA16B5C5Q51074281-36B36B50-BB59-448F-B699-60158AD3CF7FQ51818445-217E38E5-BBA8-4F97-BCC6-A010F20926EF
P2860
High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
High prevalence of cytomegalov ...... onnection with seroconversion.
@en
High prevalence of cytomegalov ...... onnection with seroconversion.
@nl
type
label
High prevalence of cytomegalov ...... onnection with seroconversion.
@en
High prevalence of cytomegalov ...... onnection with seroconversion.
@nl
prefLabel
High prevalence of cytomegalov ...... onnection with seroconversion.
@en
High prevalence of cytomegalov ...... onnection with seroconversion.
@nl
P2093
P2860
P1433
P1476
High prevalence of cytomegalov ...... onnection with seroconversion.
@en
P2093
Alexander Unmack
Holger Hennig
Sabine Krueger
Siegfried Goerg
P2860
P304
P356
10.1111/J.1537-2995.2007.01420.X
P577
2007-11-01T00:00:00Z